REVIEW OF CURRENT RESEARCH ON CHITOSAN AS A RAW MATERIAL IN THREE-DIMENSIONAL PRINTING TECHNOLOGY IN BIOMEDICAL APPLICATIONS | Zendy

Szymon Mania | Zendy; Adrianna BanachKopeć | Zendy; Robert Tylingo | Zendy

Open Access

REVIEW OF CURRENT RESEARCH ON CHITOSAN AS A RAW MATERIAL IN THREE-DIMENSIONAL PRINTING TECHNOLOGY IN BIOMEDICAL APPLICATIONS

Author(s) -

Szymon Mania,

Adrianna BanachKopeć,

Robert Tylingo

Publication year - 2020

Publication title -

progress on chemistry and application of chitin and its derivatives

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.181

H-Index - 10

ISSN - 1896-5644

DOI - 10.15259/pcacd.25.003

Subject(s) - stereolithography , chitosan , 3d printing , nanotechnology , biomaterial , tissue engineering , materials science , selective laser sintering , 3d bioprinting , biomedical engineering , computer science , process engineering , engineering , sintering , chemical engineering , composite material

Three-dimensional (3D) biomaterial manufacturing strategies show an extraordinary driving force for the development of innovative solutions in the biomedical sector, including drug delivery systems, disease modelling and tissue and organ engineering. Due to its remarkable and promising biological and structural properties, chitosan has been widely studied for decades in several potential applications in the biomedical field. However, tools in the form of 3D printers have created new possibilities for the production of chitosan models, implants and scaffolds for cell cultures that are much more precise than existing ones. The article presents current achievements related to the possibility of using chitosan to create new materials for 3D printing in the form of chitosan bioinks, filaments, resins and powders dedicated for bioprinting, fused deposition modelling, stereolithography/digital light processing and selective laser sintering methods, respectively

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research